Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2016
Drugs and Therapeutics (D & T) Committee
Drugs Under Review for:
September 14, 2016
| Drug Name | Review Type | Class | Manufacturer |
| Viekira HR | New Drug Initial Review | Hepatitis C | AbbVie |
| Ocaliva | New Drug Initial Review | Primary Biliary Cholangitis | Intercept Pharmaceuticals |
| Briviact | New Drug Initial Review | Anticonvulsant | UCB, Inc. |
| Epclusa | New Drug Initial Review | Hepatitis C | Gilead Sciences |
| Xtampza ER | New Drug Initial Review | Extended Release Opioid | Collegium Pharmaceutical |
| Spinosad | New Drug Initial Review | Lice Treatment | ParaPro |
| Adzenys XR-ODT | New Drug Initial Review | Stimulant | Neos Therapeutics |
| Orenitram | New Drug Appeal | Pulmonary Arterial Hypertension | United Therapeutics |